Literature DB >> 25278611

Prostate cancer. Ubiquitylome analysis identifies dysregulation of effector substrates in SPOP-mutant prostate cancer.

Jean-Philippe P Theurillat1,2,3, Namrata D Udeshi1, Wesley J Errington4,5, Tanya Svinkina1, Sylvan C Baca2,3, Marius Pop1,2,3, Peter J Wild6, Mirjam Blattner7, Anna C Groner3, Mark A Rubin7,8, Holger Moch6, Gilbert G Prive4,5, Steven A Carr1, Levi A Garraway1,2,3,9.   

Abstract

Cancer genome characterization has revealed driver mutations in genes that govern ubiquitylation; however, the mechanisms by which these alterations promote tumorigenesis remain incompletely characterized. Here, we analyzed changes in the ubiquitin landscape induced by prostate cancer-associated mutations of SPOP, an E3 ubiquitin ligase substrate-binding protein. SPOP mutants impaired ubiquitylation of a subset of proteins in a dominant-negative fashion. Of these, DEK and TRIM24 emerged as effector substrates consistently up-regulated by SPOP mutants. We highlight DEK as a SPOP substrate that exhibited decreases in ubiquitylation and proteasomal degradation resulting from heteromeric complexes of wild-type and mutant SPOP protein. DEK stabilization promoted prostate epithelial cell invasion, which implicated DEK as an oncogenic effector. More generally, these results provide a framework to decipher tumorigenic mechanisms linked to dysregulated ubiquitylation.
Copyright © 2014, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25278611      PMCID: PMC4257137          DOI: 10.1126/science.1250255

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  29 in total

1.  Methods for quantification of in vivo changes in protein ubiquitination following proteasome and deubiquitinase inhibition.

Authors:  Namrata D Udeshi; D R Mani; Thomas Eisenhaure; Philipp Mertins; Jacob D Jaffe; Karl R Clauser; Nir Hacohen; Steven A Carr
Journal:  Mol Cell Proteomics       Date:  2012-04-14       Impact factor: 5.911

Review 2.  Non-canonical ubiquitin-based signals for proteasomal degradation.

Authors:  Yelena Kravtsova-Ivantsiv; Aaron Ciechanover
Journal:  J Cell Sci       Date:  2012-02-01       Impact factor: 5.285

3.  DEK regulates hematopoietic stem engraftment and progenitor cell proliferation.

Authors:  Hal E Broxmeyer; Ferdinand Kappes; Nirit Mor-Vaknin; Maureen Legendre; John Kinzfogl; Scott Cooper; Giao Hangoc; David M Markovitz
Journal:  Stem Cells Dev       Date:  2011-10-27       Impact factor: 3.272

4.  Large-scale identification of ubiquitination sites by mass spectrometry.

Authors:  Namrata D Udeshi; Philipp Mertins; Tanya Svinkina; Steven A Carr
Journal:  Nat Protoc       Date:  2013-09-19       Impact factor: 13.491

5.  The translocation (6;9), associated with a specific subtype of acute myeloid leukemia, results in the fusion of two genes, dek and can, and the expression of a chimeric, leukemia-specific dek-can mRNA.

Authors:  M von Lindern; M Fornerod; S van Baal; M Jaegle; T de Wit; A Buijs; G Grosveld
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

6.  SPOP promotes tumorigenesis by acting as a key regulatory hub in kidney cancer.

Authors:  Guoqiang Li; Weimin Ci; Subhradip Karmakar; Ke Chen; Ruby Dhar; Zhixiang Fan; Zhongqiang Guo; Jing Zhang; Yuwen Ke; Lu Wang; Min Zhuang; Shengdi Hu; Xuesong Li; Liqun Zhou; Xianghong Li; Matthew F Calabrese; Edmond R Watson; Sandip M Prasad; Carrie Rinker-Schaeffer; Scott E Eggener; Thomas Stricker; Yong Tian; Brenda A Schulman; Jiang Liu; Kevin P White
Journal:  Cancer Cell       Date:  2014-03-20       Impact factor: 31.743

7.  Prevention of amino acid conversion in SILAC experiments with embryonic stem cells.

Authors:  Sean C Bendall; Chris Hughes; Morag H Stewart; Brad Doble; Mickie Bhatia; Gilles A Lajoie
Journal:  Mol Cell Proteomics       Date:  2008-05-16       Impact factor: 5.911

8.  BTB domain-containing speckle-type POZ protein (SPOP) serves as an adaptor of Daxx for ubiquitination by Cul3-based ubiquitin ligase.

Authors:  Jeong Eun Kwon; Muhnho La; Kyu Hee Oh; Young Mi Oh; Gi Ryang Kim; Jae Hong Seol; Sung Hee Baek; Tomoki Chiba; Keiji Tanaka; Ok Sun Bang; Cheol O Joe; Chin Ha Chung
Journal:  J Biol Chem       Date:  2006-03-08       Impact factor: 5.157

9.  The human DEK oncogene stimulates β-catenin signaling, invasion and mammosphere formation in breast cancer.

Authors:  L M Privette Vinnedge; R McClaine; P K Wagh; K A Wikenheiser-Brokamp; S E Waltz; S I Wells
Journal:  Oncogene       Date:  2011-02-14       Impact factor: 9.867

10.  Structures of SPOP-substrate complexes: insights into molecular architectures of BTB-Cul3 ubiquitin ligases.

Authors:  Min Zhuang; Matthew F Calabrese; Jiang Liu; M Brett Waddell; Amanda Nourse; Michal Hammel; Darcie J Miller; Helen Walden; David M Duda; Steven N Seyedin; Timothy Hoggard; J Wade Harper; Kevin P White; Brenda A Schulman
Journal:  Mol Cell       Date:  2009-10-09       Impact factor: 17.970

View more
  106 in total

Review 1.  Dysregulation of ubiquitin ligases in cancer.

Authors:  Jianfei Qi; Ze'ev A Ronai
Journal:  Drug Resist Updat       Date:  2015-09-28       Impact factor: 18.500

Review 2.  Moving Beyond the Androgen Receptor (AR): Targeting AR-Interacting Proteins to Treat Prostate Cancer.

Authors:  Christopher Foley; Nicholas Mitsiades
Journal:  Horm Cancer       Date:  2016-01-04       Impact factor: 3.869

Review 3.  Cellular and Molecular Mechanisms Underlying Prostate Cancer Development: Therapeutic Implications.

Authors:  Ugo Testa; Germana Castelli; Elvira Pelosi
Journal:  Medicines (Basel)       Date:  2019-07-30

4.  Speckle-type POZ protein is negatively associated with malignancies and inhibits cell proliferation and migration in liver cancer.

Authors:  Yuping Huang; Ning Tan; Deshui Jia; Ying Jing; Qifeng Wang; Zhe Li; Jiwei Zhang; Li Liu; Jinjun Li; Zhiao Chen; Xianghuo He
Journal:  Tumour Biol       Date:  2015-07-10

Review 5.  Quantifying ubiquitin signaling.

Authors:  Alban Ordureau; Christian Münch; J Wade Harper
Journal:  Mol Cell       Date:  2015-05-21       Impact factor: 17.970

Review 6.  Implications of ubiquitin ligases in castration-resistant prostate cancer.

Authors:  Jianfei Qi; Lingling Fan; Arif Hussain
Journal:  Curr Opin Oncol       Date:  2015-05       Impact factor: 3.645

7.  Multiple Weak Linear Motifs Enhance Recruitment and Processivity in SPOP-Mediated Substrate Ubiquitination.

Authors:  Wendy K Pierce; Christy R Grace; Jihun Lee; Amanda Nourse; Melissa R Marzahn; Edmond R Watson; Anthony A High; Junmin Peng; Brenda A Schulman; Tanja Mittag
Journal:  J Mol Biol       Date:  2015-10-22       Impact factor: 5.469

8.  MicroRNA-424 impairs ubiquitination to activate STAT3 and promote prostate tumor progression.

Authors:  Cecilia Dallavalle; Domenico Albino; Gianluca Civenni; Jessica Merulla; Paola Ostano; Maurizia Mello-Grand; Simona Rossi; Marco Losa; Gioacchino D'Ambrosio; Fausto Sessa; George N Thalmann; Ramon Garcia-Escudero; Andrea Zitella; Giovanna Chiorino; Carlo V Catapano; Giuseppina M Carbone
Journal:  J Clin Invest       Date:  2016-11-07       Impact factor: 14.808

9.  Speckle-type POZ (pox virus and zinc finger protein) protein gene deletion in ovarian cancer: Fluorescence in situ hybridization analysis of a tissue microarray.

Authors:  Xiaoyu Hu; Zhu Yang; Manman Zeng; Y I Liu; Xiaotao Yang; Yanan Li; X U Li; Qiubo Yu
Journal:  Oncol Lett       Date:  2016-05-30       Impact factor: 2.967

10.  Systematic Prioritization of Druggable Mutations in ∼5000 Genomes Across 16 Cancer Types Using a Structural Genomics-based Approach.

Authors:  Junfei Zhao; Feixiong Cheng; Yuanyuan Wang; Carlos L Arteaga; Zhongming Zhao
Journal:  Mol Cell Proteomics       Date:  2015-12-09       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.